Dear Label_Name,

Greetings! I hope you are well.

I am writing on behalf of an international publishing house, Science and Education Publishing, USA (http://www.sciepub.com).

Science and Education Publishing (SciEP) is a multidisciplinary open access publisher of Journals covering the fields of Science, Technology and Medicine. All SciEP publications are subject to high-quality peer review, editorial and production processes and are freely available online.

Welcome to the April, 2013 edition of SciEP newsletter, providing monthly summaries of articles on science & education related topics of interest to scientist and professionals. The mission of our journals is to provide an open access forum for publishing new findings on issues pertinent to scientific and academic field. We also invite you to submit original research papers, review articles, short reports, or case studies are considered for publication in our Multidisciplinary Journals.

American Journal of Public Health Research
DOI: 10.12691/ajphr-1-1-3

The Implementation of a Tele-Homecare System with Service Oriented Architecture and HL7 Message Transmission Standard
Ching-Sung Wang

American Journal of Medical and Biological Research
DOI: 10.12691/ajmbr-1-1-2

The Influence of Ethanol on Pyruvate Kinases Activity in Vivo, in Vitro, in Silico
Lelevich Sergey Vladimirovich, Khrustalev Vladislav Victorovich, Barkovsky Eugene Victorovich, Shedogubova Tatyana Aleksandrovna

American Journal of Medical Sciences and Medicine
DOI: 10.12691/ajmsm-1-1-1

Clinical and Histological Features in Wegener Granulomatosis
Li Cavoli Gioacchino, Passantino Rita, Bono Luisa, Tortorici Calogera, Ferrantelli Angelo, Giammarresi Carlo, Rotolo Ugo

American Journal of Infectious Diseases and Microbiology
DOI: 10.12691/ajidm-1-1-2

The Curse of Lymphatic Filariasis: Would the Continual Use of Diethylcarbamazine Eliminate this Scourge in Papua New Guinea?
Anne Lanham, Lillian Mwanri

We have released issues of some journals on February 2013.
American Journal of Public Health Research
American Journal of Medical Sciences and Medicine
American Journal of Medical and Biological Research
American Journal of Pharmacological Sciences
American Journal of Clinical Medicine Research
American Journal of Nursing Research
American Journal of Cancer Prevention
American Journal of Medicine Studies
American Journal of Infectious Diseases and Microbiology
American Journal of Cardiovascular Disease Research
American Journal of Biomedical Research
American Journal of Mechanical Engineering
American Journal of Microbiological Research
Journal of Preventive Medicine
American Journal of Food and Nutrition
American Journal of Hypertension Research
American Journal of Sports Science and Medicine
Journal of Cancer Research and Treatment
American Journal of Zoological Research
Journal of Biomedical Engineering and Technology
American Journal of Microbiological Research
Biomedical Science and Engineering

We are pleased to announce that submissions are now being accepted for peer review for all the journals across all our subject areas in SciEP.

Please submit your manuscript via our online submission system:
http://www.sciepub.com/author/signin

To unsubscribe from our mailing list, please click on the following link: unsubscribe

I am looking forward to hearing from you.

Kind regards,

David Rain
Email:join@sciepub.com
Science and Education Publishing (http://www.sciepub.com)

Severe Thrombocytopenia in a Young Patient with EBV Induced Infectious Mononucleosis: An Extremely Rare and Life-threatening Complication

Asghar Marwat*, Hassan Mehmood, Muzammil Khan

Department of Internal Medicine, Temple University/ Conemaugh Memorial Medical Center, 1086 Franklin Street, Johnstown, PA, USA, 15905

Abstract: Epstein-Barr virus is a widely disseminated herpes virus. Humans are the main reservoir. Acute infectious mononucleosis is one of the most common presentations of acute EBV infection. Although mild thrombocytopenia is a common complication of EBV induced infectious mononucleosis, severe thrombocytopenia with counts less than 25,000/mm³ is extremely rare and infrequently reported. We herein, present a 22-year-old Caucasian male with no past medical history who came to our hospital with complaints of fever, sore throat, swollen lymph nodes and intermittent bleeding from his gums for the last 4 weeks. On physical examination, the patient had enlarged tonsils and cervical lymphadenopathy, however, no rashes or hepatosplenomegaly were noted. On initial Lab work the patient had a platelet count of 11,000/mm³, WBC count of 9,800 with 31% atypical Lymphocytes and a positive mono spot test. The patient also had a peripheral smear showing marked thrombocytopenia. EBV infection was further confirmed by serology including EBV-PCR. Other possible causes of thrombocytopenia including HIV and Hepatitis C were tested and found to be negative. The patient was treated with platelet transfusion and intravenous steroids. He was discharged three days later, after his platelet count improved to 36,000/mm³ on a tapering dose of steroids. Two weeks later repeat lab work revealed that his platelet count had dropped again significantly to 2000/mm³. He was readmitted and this time treated with Intravenous Immunoglobulin and intravenous steroids. The patient had dramatic improvement and his platelet count was 143,000/mm³ two days later. The patient was discharged and continued to have normal platelet counts during routine clinic follow ups few months later. Severe thrombocytopenia is a potentially life-threatening condition. Although exceptionally rare, severe thrombocytopenia can occur as a complication of EBV induced Infectious mononucleosis and should be considered by physicians as a possible differential for thrombocytopenia in the right clinical setting. Steroids and Intravenous Immunoglobulin have been used with varying success to treat this complication.

Keywords: thrombocytopenia AND EBV infection

Citation: Asghar Marwat, Hassan Mehmood, Muzammil Khan, Severe Thrombocytopenia in a Young Patient with EBV Induced Infectious Mononucleosis: An Extremely Rare and Life-threatening Complication. American Journal of Medical Case Reports, 6 (2). 24-25. January 2018. doi:10.12691/ajmcr-6-2-3

1. Introduction

Epstein Bar Virus [EBV] is a widely distributed member of the herpes virus family spread through intimate contact between asymptomatic EBV shedders and vulnerable individuals [1]. Acute infectious mononucleosis is the most well-known manifestation of EBV infection [2]. Although EBV associated infectious mononucleosis results in some reduction of platelet counts in 50% of the cases [3], severe thrombocytopenia with platelet counts less than 25,000/mm³ is extremely rare and infrequently reported [4,5]. We present a case of a 22-year-old male patient with severe thrombocytopenia and concomitant EBV induced infectious mononucleosis.

2. Case

An otherwise healthy 22-year-old Caucasian male presented to the Conemaugh memorial medical center Emergency Department with complaints of sore throat, fever (100⁰F) and cervical lymphadenopathy for the past 4 weeks. The patient also reported bleeding from his gums intermittently, and had recently completed a course of antibiotics for strep throat. On Physical examination, the patient had bilateral enlarged tonsils with exudates and bilateral cervical lymphadenopathy, no hepatosplenomegaly was noted. Initial laboratory testing revealed a Hemoglobin of 17.2 mg/dl, Hematocrit of 49%, WBC count of 9800/mm³with 31% atypical lymphocytes on manual differential as well as a platelet count of 11000/mm³. The results of a mono spot test and throat culture for Group A Beta strep were also positive. The patient was admitted and transfused two units of platelets, he was started on methylprednisolone 40mg every 8 hours, Azithromycin 500mg daily. During admission, further testing was obtained along with peripheral smear which showed marked thrombocytopenia with normal WBC count and relative lymphocytosis. EBV specific serology was obtained and both EBV anti IgM and IgG antibodies were positive, this was further confirmed with quantitative EBV-PCR revealing 2150 copies/mm³. Serological tests for HIV and Hep C were negative. Additionally, platelet antibody screen was positive. Hepatic Function Tests showed PT/INR of 1.1 while AST and ALT were mildly elevated at 60 and 133 respectively. The patient did not show any sign of bleeding, he continued to improve clinically and 3 days later his platelet count was 36000/mm³. The patient was subsequently discharged on a tapering dose of prednisone and oral antibiotics. However, follow up CBC has done two weeks later the patient was once again found to be thrombocytopenic with a platelet count of 2000/mm³. He was again admitted and started on steroids 1mg/kg/ day and was also given Intravenous Immunoglobulin. The patient this time showed dramatic improvement in his platelet counts and two days later his counts were 143000/mm. The patient was subsequently discharged home on a tapering dose of steroids. On routine follow in the outpatient clinic a few months later the patient continued to have normal platelet counts.

3. Discussion

The bulk of EBV infections worldwide is asymptomatic and EBV antibodies are seen in all population groups with 90-95% of all adults being EBV positive [6]. Although EBV is implicated in the pathogenesis of several malignancies [1], Infectious mononucleosis is the most famous clinical entity associated with EBV infection [2]. Infectious mononucleosis classically consists of a triad fever, tonsillar enlargement, and lymphadenopathy [7]. All three clinical features were present in our patient. One of the features of EBV induced infectious mononucleosis is a reduction in platelet counts. Although mild to moderate thrombocytopenia with platelet counts ranging from [63,000/mm³ to 139,000/mm³] have seen in most of the patients with EBV induced infectious mononucleosis [3], severe thrombocytopenia with counts below 2,000/mm³ are rarely seen [4]. According to Michelle L Pipp et al there were only 36 cases of severe thrombocytopenia [platelet counts less than 2,000/mm³] as a complication of EBV induced infectious mononucleosis reported between 1965-1997, [4]. In patients with low platelet counts irrespective of etiology severe thrombocytopenia defined as a platelet count below 50,000/mm³, poses the greatest risk for bleeding [8]. Life threatening hemorrhagic complications like major Intracranial Hemorrhage [ICH] and non-ICH sever bleeding is observed when platelet counts fall below 10,000-20,000 [9]. The cause of severe thrombocytopenia in patients with EBV induced infectious mononucleosis is hypothesized to be immune mediated [3]. Our patient was also positive for anti-platelet antibodies. However, further studies need to be conducted to determine the prevalence of anti-platelet antibodies in patients with EBV induced infectious mononucleosis complicated by severe thrombocytopenia. Treatment of severe thrombocytopenia in EBV induced infectious mononucleosis can be challenging and patients may relapse even after initial response to treatment [10]. This was the case in our patient who initially responded to treatment with improvement in platelet counts, however two weeks later his platelet counts had dropped once again on repeat blood work. Although exceptionally rare, severe thrombocytopenia can occur as a complication of EBV induced infectious mononucleosis. Only a subset of patients with severe thrombocytopenia will go on to develop life threatening bleeding diathesis [4]. EBV infection should be considered as one of the differentials for patients with severe thrombocytopenia in the right clinical setting. Although there have been mixed results and varying success with Steroids and Intravenous Immunoglobulin in the treatment of severe thrombocytopenia in some cases, like in our patient there may be complete resolution and return to baseline platelet count.

4. Conclusion

Severe thrombocytopenia in individuals with EBV induced infectious mononucleosis can be potentially fatal, making its early diagnosis and treatment vital for clinicians. We recommend awareness among healthcare professionals about this extremely rare complication of a very common disease.

References

[1]   | Odumade OA, Hogquist KA, Balfour HH Jr. Progress and problems in understanding and managing primary Epstein-Barr virus infections. Clin Microbiol Rev 2011; 24:193.
[2]   | Dunmire SK, Hogquist KA, Balfour HH. Infectious Mononucleosis. Curr Top Microbiol Immunol 2015; 390:211.
[3]   | Carter RL: Platelet Levels in infectious mononucleosis. Blood 1965; 25:817-821.
[4]   | Pipp ML, Means ND, Sixbey JW, Morris KL, Gue CL, Baddour LM. Acute Epstein-Barr virus infection complicated by severe thrombocytopenia. Clin Infect Dis. 1997 Nov; 25(5): 1237-9.
[5]   | Steeper TA, Horwitz CA, Moore SB, et al: Severe thrombocytopenia in Epstein-Barr virus-induced mononucleosis. West J Med 1989 Feb; 150:170-173
[6]   | Miller G, Shope T, Lisco H, et al. Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes. Proc Natl Acad Sci U S A 1972; 69: 383.
[7]   | Luzuriaga K, Sullivan JL. Infectious mononucleosis. N Engl J Med 2010; 362: 1993.
[8]   | Williamson DR, Albert M, Heels-Ansdell D, et al. Thrombocytopenia in critically ill patients receiving thromboprophylaxis: frequency, risk factors, and outcomes. Chest 2013; 144: 1207.
[9]   | Neunert C, Noroozi N, Norman G, et al. Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review. J Thromb Haemost 2015; 13:457.
[10]   | Mazza J, Magnin G. Severe thrombocytopenia in infection mononucleosis. Wis Med J 1975; 74: 124-127.